Evidence map›Paper›PMID 37902236›Full record

ArticleCancer medicine2023

The effect of body mass index on quality of life in modified single stoma cutaneous ureterostomy or ileal conduit after radical cystectomy.

Wan-Jin Zhang, Xu-Yun Huang, Bin Lin, Wen-Cai Zheng, Zhi-Bin Ke, Xiao-Dan Lin, Jia-Yin Chen, Hai Cai, Yun-Zhi Lin, Ye-Hui Chen and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

Wan-Jin ZhangDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Xu-Yun HuangDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Bin LinDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Wen-Cai ZhengDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Zhi-Bin KeDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Xiao-Dan LinDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Jia-Yin ChenDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Hai CaiDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Yun-Zhi LinDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Ye-Hui ChenDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Qing-Shui ZhengDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
Yong WeiDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.ORCID 0000-0001-5324-3733
Xue-Yi XueDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.ORCID 0000-0002-6461-7435
Xiao-Dong LiDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.ORCID 0000-0002-0517-5112
Ning XuDepartment of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.ORCID 0000-0001-7909-7025
Fujian Medical University · CN

Funding

Class B Talent Research Project of the First Affiliated Hospital of Fujian Medical University YCRC-B-XN2022Fujian Province Finance Project 2020B018Natural Science Foundation of Fujian Province 2021J01715the "Eyas Plan" Youth Top-notch Talent Project of Fujian Province SCYJHBJRC-XN2021
6 · The paper itself

Abstract

objectiveTo explore the influence of postoperative body mass index (BMI) change on postoperative quality of life (QOL) in patients undergoing radical cystectomy (RC) plus modified single stoma cutaneous ureterostomy (MSSCU) or ileal conduit (IC).

methodsPatients were divided into two groups according to different BMI change patterns: patients experiencing an elevated postoperative BMI level, along with a clinically significant increase in their BMI (an increase of more than 10%) were categorized as Group 1, while patients experiencing a decrease postoperative BMI level, along with a clinically significant reduction in their BMI (a decrease of more than 5%) were categorized as Group 2. Spearman correlation analysis was used to examine the correlations between quality-of-life scores and postoperative clinical parameters.

resultsSpearman correlation analysis showed that postoperative BMI, late complications and catheter-free state were significantly associated with postoperative global QoL and symptom scale in MSSCU and postoperative global QoL and physical scale in IC patients. Additionally, postoperative BMI, catheter-free state and the use of adjuvant therapy were associated with bad performance in many scales of QoL like body image, future perspective, social scale, future perspective (MSSCU), and abdominal bloating (IC) (Table 2, p<0.05). Patients in Group 2 with significant weight loss had a better Global QoL, a lower rate of stomal stricture and a higher catheter-free state compared with those in Group 1 in both IC and MSSCU patients. MSSCU patients in Group 2 could achieve a comparable Global QoL as to IC patients in Group 1.

conclusionControlling the substantial increase in body weight after surgery contributes to improving QoL, reducing the occurrence of stomal stricture, and ensuring a postoperative catheter-free state in BCa patients undergoing MSSCU.

Indexed as

Urinary Bladder NeoplasmsUrinary DiversionBody Mass IndexConstriction, PathologicCystectomyHumansPostoperative ComplicationsQuality of LifeUreterostomybladder cancerbody mass indexileal conduitmodified single stoma cutaneous ureterostomyquality of life

Identifiers

PMID37902236
PMCPMC10709730
OpenAlexW4388014875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.